HROW · Company research
Harrow, Inc. Common Stock (HROW): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
20records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Harrow, Inc. (HROW) Stock Price, News, Quote & History - Yahoo! Finance Canada | Harrow, Inc. (HROW) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 10, 2026 | neutral | 0 | 0.6 |
| Do Options Traders Know Something About Harrow Stock We Don't? | Harrow, Inc. (HROW) is drawing attention due to high implied volatility in its October 2026 $15.00 call options, suggesting traders expect significant price movement. However, the company holds a Zacks Rank #3 (Hold) rating in the Medical-Drugs industry, with analyst consensus estimates declining from 94 cents to 87 cents per share over the last 60 days. The elevated implied volatility may present opportunities for premium-selling strategies rather than directional bets. | View source ↗ | Zacks Investment Research | Oct 9, 2026 | bearish | -1 | 1 |
| Do Options Traders Know Something About Harrow Stock We Don't? | Harrow, Inc. (HROW) is drawing attention due to high implied volatility in its October 2026 $15.00 call options, suggesting traders expect significant price movement. However, the company holds a Zacks Rank #3 (Hold) rating in the Medical-Drugs industry, with analyst consensus estimates declining from 94 cents to 87 cents per share over the last 60 days. The elevated implied volatility may present opportunities for premium-selling strategies rather than directional bets. | View source ↗ | Zacks Investment Research | Oct 9, 2026 | bearish | -1 | 1 |
| Harrow, Inc. (HROW) stock price, news, quote and history - Yahoo Finance UK | Harrow, Inc. (HROW) stock price, news, quote and history Yahoo Finance UK | View source ↗ | Yahoo Finance UK | Oct 9, 2026 | neutral | 0 | 0.6 |
| Harrow: Q3 Needs To Prove The Turnaround Is Real (NASDAQ:HROW) - Seeking Alpha | Harrow: Q3 Needs To Prove The Turnaround Is Real (NASDAQ:HROW) Seeking Alpha | View source ↗ | Seeking Alpha | Oct 8, 2026 | neutral | 0 | 0.6 |
| Harrow (NasdaqGM:HROW) Stock Forecast & Analyst Predictions - Simply Wall Street | Harrow (NasdaqGM:HROW) Stock Forecast & Analyst Predictions Simply Wall Street | View source ↗ | Simply Wall Street | Oct 6, 2026 | neutral | 0 | 0.6 |
| TYRVAYA is the only FDA-approved nasal spray for dry eye. Harrow acquired its rights outside Japan. - Stock Titan | TYRVAYA is the only FDA-approved nasal spray for dry eye. Harrow acquired its rights outside Japan. Stock Titan | View source ↗ | Stock Titan | Oct 5, 2026 | neutral | 0 | 0.6 |
| (HROW) Risk Channels and Responsive Allocation - Stock Traders Daily | (HROW) Risk Channels and Responsive Allocation Stock Traders Daily | View source ↗ | Stock Traders Daily | Oct 2, 2026 | neutral | 0 | 0.6 |
| HROW News | HARROW INC (NASDAQ:HROW) - ChartMill | HROW News | HARROW INC (NASDAQ:HROW) ChartMill | View source ↗ | ChartMill | Sep 29, 2026 | neutral | 0 | 0.6 |
| Is Harrow Inc (HROW) a Bargain After 3.2% Drop? GF Value Says Un - GuruFocus | Is Harrow Inc (HROW) a Bargain After 3.2% Drop? GF Value Says Un GuruFocus | View source ↗ | GuruFocus | Sep 17, 2026 | neutral | 0 | 0.6 |
| Harrow (NASDAQ: HROW) CSO sells 11,250 shares in August option trade - Stock Titan | Harrow (NASDAQ: HROW) CSO sells 11,250 shares in August option trade Stock Titan | View source ↗ | Stock Titan | Aug 21, 2026 | neutral | 0 | 0.6 |
| In a 50-patient study, Harrow’s eye gel was linked to about 58% less injection discomfort - Stock Titan | In a 50-patient study, Harrow’s eye gel was linked to about 58% less injection discomfort Stock Titan | View source ↗ | Stock Titan | Aug 20, 2026 | neutral | 0 | 0.6 |
| Harrow (HROW) Stock Grapples With Losses Despite Double Digit Revenue Growth - Simply Wall Street | Harrow (HROW) Stock Grapples With Losses Despite Double Digit Revenue Growth Simply Wall Street | View source ↗ | Simply Wall Street | Aug 11, 2026 | neutral | 0 | 0.6 |
| Harrow (HROW) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance | Harrow (HROW) Reports Q2 Loss, Misses Revenue Estimates Yahoo Finance | View source ↗ | Yahoo Finance | Aug 10, 2026 | neutral | 0 | 0.6 |
| HROW Stock Rises on Relaunch of Ophthalmology Drug Verkazia in the US - Zacks Investment Research | HROW Stock Rises on Relaunch of Ophthalmology Drug Verkazia in the US Zacks Investment Research | View source ↗ | Zacks Investment Research | Jun 11, 2026 | neutral | 0 | 0.6 |
| HROW Stock Rips Higher As Traders Digest Mixed Quarter - Timothy Sykes | HROW Stock Rips Higher As Traders Digest Mixed Quarter Timothy Sykes | View source ↗ | Timothy Sykes | Jun 10, 2026 | neutral | 0 | 0.6 |
| $HROW stock is down 21% today. Here's what we see in our data. - Quiver Quantitative | $HROW stock is down 21% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | May 12, 2026 | neutral | 0 | 0.6 |
| Harrow Inc. (HROW) stock falls on Q1 2026 Earnings - Quiver Quantitative | Harrow Inc. (HROW) stock falls on Q1 2026 Earnings Quiver Quantitative | View source ↗ | Quiver Quantitative | May 11, 2026 | neutral | 0 | 0.6 |
| Is Harrow, Inc. (HROW) A Good Stock To Buy Now? - Yahoo Finance | Is Harrow, Inc. (HROW) A Good Stock To Buy Now? Yahoo Finance | View source ↗ | Yahoo Finance | Apr 30, 2026 | neutral | 0 | 0.6 |
| HARROW INC (NASDAQ:HROW): A GARP Stock with Strong Growth at a Reasonable Price - ChartMill | HARROW INC (NASDAQ:HROW): A GARP Stock with Strong Growth at a Reasonable Price ChartMill | View source ↗ | ChartMill | Mar 26, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.